The Operator's Guide to Production-Scale 3D Printing: When Additive Manufacturing Becomes Your Supply Chain

For the past decade, 3D printing in pharmaceutical and medtech manufacturing has lived in a controlled limbo. It could make complex geometries, reduce lead times, and eliminate certain supply chain vulnerabilities. But the technology remained a solution in search of a problem large enough to justify the regulatory burden and the per-unit cost premium. That calculus has inverted. As of early 2026, additive manufacturing has achieved what the industry calls "production parity": the unit economics, throughput rates, and material consistency now support scaled manufacturing runs for both active pharmaceutical ingredients (APIs) and critical device components. This is not incremental progress. This represents a fundamental shift in how operations teams must think about qualification, invento